| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 08/21/2013 | CN101663313B Nucleotide with an alpha-phosphate mimetic |
| 08/20/2013 | US8513406 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 08/20/2013 | US8513399 Primers for PCR amplification comprising a basic parts within the primer sequences |
| 08/20/2013 | US8513215 Compositions for the treatment or prophylaxis of viral infections |
| 08/20/2013 | US8513214 C4′-substituted-2-deoxyadenosine analogs and methods of treating HIV |
| 08/15/2013 | US20130211067 Novel seleny-methyluracil compounds, radiosensitizer and pharmaceutical composition using them |
| 08/15/2013 | US20130211066 Compounds useful in imaging and therapy |
| 08/15/2013 | US20130211065 Purification of synthetic oligonucleotides |
| 08/15/2013 | US20130210757 Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs |
| 08/15/2013 | US20130210664 Methods for the Identification of Methyltransferase Interacting Molecules and for the Purification of Methyltransferase Proteins |
| 08/14/2013 | EP2625281A2 Cyanine compounds, conjugates and method of use |
| 08/14/2013 | EP2625187A1 Phosphoramidite derivatives of gemcitabine for use in the treatment cancer |
| 08/14/2013 | EP2625186A2 5' modified nucleosides and oligomeric compounds prepared therefrom |
| 08/14/2013 | EP2625181A2 Method of preparation of antiviral compounds and useful intermediates thereof |
| 08/14/2013 | CN103242404A N-rhamnose benzocarbazole compound, and synthetic method and application thereof in pharmacy |
| 08/14/2013 | CN103242403A High-purity dibutyryladenosine cyclophosphate calcium and preparation method thereof |
| 08/14/2013 | CN103242402A Method for quickly preparing high-purity N6-(2-ethoxy) adenosine |
| 08/14/2013 | CN103242401A Preparation of tamibarotene-cytarabine conjugate and nano pharmacosomes and anti-tumor application of tamibarotene-cytarabine conjugate and nano pharmacosomes |
| 08/14/2013 | CN103242400A 5-substituted pyrimidine nucleoside-thiazolidinone hybrid with anti-HIV activity and preparation method thereof |
| 08/14/2013 | CN101730704B Stable salts of s-adenosylmethionine and process for the preparation thereof |
| 08/13/2013 | US8507460 Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections |
| 08/13/2013 | US8507226 Methods for high fidelity production of long nucleic acid molecules |
| 08/13/2013 | US8506926 [18F]-furanosylpurine derivatives and uses thereof |
| 08/13/2013 | CA2629250C Stable salt of 3'-phosphoadenosine 5'-phosphosulfate |
| 08/08/2013 | US20130203978 Nucleosides with antiviral and anticancer activity |
| 08/08/2013 | US20130203836 2' and 5' modified monomers and oligonucleotides |
| 08/08/2013 | US20130203694 Compounds for treating bacterial infections |
| 08/07/2013 | EP2623104A1 Substituted nucleoside and nucleotide analogs |
| 08/07/2013 | CN103237805A Block synthesis of oligoribonucleotides |
| 08/07/2013 | CN103232512A Method for preparing beta-enriched Decitabine precursor |
| 08/07/2013 | CN103232511A Light-cleavable group protected deoxyuridine triphosphate derivatives and a synthesis method and applications thereof. |
| 08/07/2013 | CN103232510A 5'-amino-2',5'-dideoxynucleotide phospholipid molecules, and preparation method and application thereof |
| 08/07/2013 | CN103232509A Fluorouracil compound, and preparation method and application thereof |
| 08/07/2013 | CN103232508A Industrialized gemcitabine hydrochloride synthesis method |
| 08/07/2013 | CN103232507A Modified nucleoside monomers, and synthesizing methods and application thereof |
| 08/07/2013 | CN101631796B Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid |
| 08/07/2013 | CN101469008B Capecitabine hydroxy derivatives, preparation thereof and use in capecitabine preparation |
| 08/06/2013 | US8501931 Convertible nucleoside derivatives |
| 08/06/2013 | US8501709 Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production |
| 08/06/2013 | US8501708 Adenosine compounds and their use thereof |
| 08/06/2013 | US8501410 Oligonucleotides for detecting human papilloma virus in a test sample |
| 08/06/2013 | US8501188 Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides |
| 08/01/2013 | WO2013112850A1 Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl) } methyl nitrate and processes of preparation thereof |
| 08/01/2013 | WO2013110902A1 Hydrogel-based decontamination of aqueous samples containing nanoparticles |
| 08/01/2013 | US20130197209 Modified nucleotides |
| 08/01/2013 | US20130197204 Novel process for the preparation of 9-deoxo-9a-aza-9a-homoerythromycin a, modified in the c-44" of the cladinose ring by an epoxide group |
| 08/01/2013 | US20130197062 Oligomeric compounds comprising tricyclic nucelosides and methods for their use |
| 08/01/2013 | US20130196941 Parenteral formulations of elacytarabine derivatives |
| 08/01/2013 | US20130196940 Anhydrous polymorphs of [(2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof |
| 07/31/2013 | EP2620428A1 Asymmetric auxiliary group |
| 07/31/2013 | EP2619216A1 Substituted nucleotide analogs |
| 07/31/2013 | EP2619215A1 Azido nucleosides and nucleotide analogs |
| 07/31/2013 | CN103224541A Gemcitabine alpha-isomer conversion recovery process |
| 07/31/2013 | CN101787066B Cytarabine derivatives and purposes thereof in resisting cancers and tumors |
| 07/30/2013 | US8497064 Nucleic acid labelling compounds |
| 07/30/2013 | CA2539588C Fused pentacyclic polyethers |
| 07/25/2013 | WO2013107041A1 Reversibly water-soluble nanocrystals capped by nucleotides and/or nucleosides |
| 07/25/2013 | US20130189743 Labelled nucleotides |
| 07/24/2013 | CN103214535A Discovery and application of novel compound in sporocarp of Cordyceps militaris (Yue96-18) bacterial classification |
| 07/24/2013 | CN103214534A Preparation method of 3'-desoxyadenossine |
| 07/24/2013 | CN103214533A Method for continuously preparing cordycepin and cordyceps polysaccharide by using membrane separation technology |
| 07/24/2013 | CN103214471A Novel compound |
| 07/23/2013 | US8492539 Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
| 07/23/2013 | US8492537 Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 07/23/2013 | US8492390 Synthesis of locked nucleic acid derivatives |
| 07/23/2013 | CA2640089C Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
| 07/23/2013 | CA2457513C Labeled nucleoside polyphosphates |
| 07/18/2013 | WO2013106344A1 2 '-c-methyl nucleosides containing a cyclic phosphate diester of 1, 3-propanediol (2-oxo-[1, 3, 2]-dioxaphosphorinane) at position 5' |
| 07/18/2013 | US20130184450 Method for preparing ribonucleoside phosphorothioate |
| 07/18/2013 | US20130184168 Immunoreactive francisella tularensis antigens |
| 07/18/2013 | US20130183712 Method and compositions for the detection of protein glycosylation |
| 07/18/2013 | US20130183339 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
| 07/17/2013 | EP2615101A1 Nucleoside derivatives, synthesis methods and uses thereof for preparing anti-tumor and anti-virus medicaments |
| 07/17/2013 | CN103209987A Substituted nucleotide analogs |
| 07/17/2013 | CN103204890A Phosphorylation method for preparing vidarabine monophosphate |
| 07/17/2013 | CN103204889A Novel Synthesis Of 5-deoxy-5'-fluorocytidine Compounds |
| 07/17/2013 | CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
| 07/17/2013 | CN102144031B DNA molecule for expressing hairpin RNA, the constructing method and the use thereof |
| 07/16/2013 | US8486620 Polymeric carriers for immunohistochemistry and in situ hybridization |
| 07/16/2013 | CA2705474C O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates |
| 07/10/2013 | EP2612147A1 Automatic immunoassay for biogenic amines |
| 07/10/2013 | CN103193843A Method for synthesizing nucleoside triphosphate and nucleoside diphosphate from all-protected nucleoside phosphoramidite intermediate through acid catalysis |
| 07/10/2013 | CN103193842A Synthesis method of capecitabine |
| 07/10/2013 | CN103193841A Therapeutic compound and relative usage method |
| 07/09/2013 | US8481715 Methods for isolating crystalline form I of 5-azacytidine |
| 07/09/2013 | US8481713 Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives |
| 07/09/2013 | US8481712 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 07/09/2013 | US8481267 Genetic fingerprinting and identification method |
| 07/09/2013 | CA2445565C Compositions and methods of double-targeting virus infections and cancer cells |
| 07/04/2013 | WO2013061105A3 Glycogen phosphorylase inhibitors |
| 07/04/2013 | WO2011139699A3 5' modified nucleosides and oligomeric compounds prepared therefrom |
| 07/04/2013 | US20130172543 Method for oxidizing alcohols |
| 07/04/2013 | US20130172542 HYDROUS CRYSTALLINE 2-O-alpha-D-GLUCOSYL-L-ASCORBIC ACID, PARTICULATE COMPOSITION COMPRISING THE SAME, THEIR PREPARATION AND USES |
| 07/04/2013 | US20130172285 Linked purine pterin hppk inhibitors useful as antibacterial agents |
| 07/03/2013 | EP2610264A2 N-[(2'r)-2'-deoxy-2'-fluoro-2'-methyl-p-phenyl-5'-uridylyl]-l-alanine 1-methylethyl ester and process for its production |
| 07/03/2013 | EP2609923A2 Nucleoside Phosphoramidates |
| 07/03/2013 | CN103183713A Preparation method of 5-deoxy-D-ribofuranose oxygen glycosides compound |
| 07/02/2013 | US8476247 Method of reducing intraocular pressure in humans |
| 06/27/2013 | WO2013096680A1 Substituted phosphorothioate nucleotide analogs |
| 06/27/2013 | WO2013096679A1 Substituted nucleosides, nucleotides and analogs thereof |